CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma
Clinical trial NCT05948033 · RECRUITING
Trial details
- NCT number
- NCT05948033
- Sponsor
- Chinese PLA General Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-15
- Primary completion
- 2025-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.